2
Manrique JL. Editorial: Comparación entre pacientes operados por cáncer colorrectal. Rev Argent Cir. 2026;118(1):e-edjlm
■
ENGLISH VERSION
Colorectal cancer (CRC) primarily affects Early diagnosis contributes to greater therapeuꢀc
1
people over 50 and is the third most common type success .
of cancer and the second leading cause of cancer-
Unꢀl 2021, the American College of
related deaths aꢃer lung cancer. Most CRCs arise from Gastroenterology treatment guidelines recommended
polypoid lesions that may precede the development of conducꢀng screening tests starꢀng at age 50 and
malignant tumors. It is esꢀmated that nearly half of all beginning earlier in paꢀents with risk factors, such as
Western adults will develop a polyp in their lifeꢀme, inflammatory bowel disease, a history of colorectal
and that one in ten of these will progress to cancer. The neoplasms, a family history of colorectal cancer, and a
2
,3
prognosis depends on cancer stage upon diagnosis, history of radiaꢀon therapy .
and survival rates are higher when cancer is detected
at early stages.
The overall incidence of cancer has decreased
in recent years, and mortality rates are declining,
The warning symptoms, which are nonspecific, primarily due to early detecꢀon. There has been an
are common to both colonic and extracolonic diseases increase in CRC cases worldwide among people under
and include rectal bleeding, changes in bowel 50, with the highest incidence in the rectum and leꢃ
4
habits, abdominal pain, iron-deficiency anemia, and colon . Over the past two decades, CRC has become
unexplained weight loss.
the leading cause of cancer death among men and the
The diagnosis is based on physical examinaꢀon, second leading cause among women in this age group
5
stool analysis, blood tests, and internal visualizaꢀon in the United States . The presence of warning signs in
of the colon. The presence of blood in the bowel is young people, such as rectal bleeding, changes in bowel
detected using simple tests such as the guaiac fecal habits, abdominal pain, iron-deficiency anemia, and
occult blood test, which reacts to traces of hemoglobin. unexplained weight loss, is associated with nearly twice
More complex tests, such as fecal immunochemical the likelihood of receiving an early-onset colorectal
tests (FIT), detect abnormaliꢀes in DNA (Cologuard) cancer diagnosis compared to having no such signs.
or RNA (Colosense) and suggest the presence of The likelihood of receiving a CRC diagnosis is six ꢀmes
6
neoplasꢀc or pre-neoplasꢀc lesions. Once the diagnosis higher if three or more of these signs are present .
of hemorrhoids has been ruled out, any posiꢀve result
must be followed up with a visual examinaꢀon.
The study by Casꢀllo Warnken et al.⁷, conducted
in Chile, offers an interesꢀng perspecꢀve on CCR in
The presence of extracellular circulaꢀng DNA people < 50 years in our region. The study is based on a
can be detected by peripheral blood tests, such as retrospecꢀve analysis of a small sample (36 paꢀents aged
Shield and ColoHealth, which serve as indicators of the 50 or younger and 119 paꢀents > 50 years). Although
presence of neoplasms. Their sensiꢀvity is high, but their findings lack staꢀsꢀcal significance, the authors
they are too expensive.
Visually guided screening includes virtual with observaꢀons made in other parts of the world.
colonoscopy, which uꢀlizes computed tomography As physicians, we must recognize the symptoms
acknowledge that they do indicate trends consistent
scans to produce images of the colon and rectum. of disease and encourage paꢀents to take these tests.
A colonoscopy examines the enꢀre colon, while a This will enable us to address the specific needs of
sigmoidoscopy examines only the leꢃ side.
Colonoscopy/sigmoidoscopy are the only
younger paꢀents.
Prevenꢀon, early detecꢀon, and advances in
methods that, in a single medical procedure, can treatment are key to reducing mortality from colorectal
visualize, examine, take samples for histological cancer. It seems reasonable to lower the screening age
examinaꢀon, remove any suspicious-looking areas to 45. considering the epidemiological changes that
8,9
polyps/cancer), and provide an accurate diagnosis. have been observed .
(
Referencias bibliográficas /References
1
.
Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK.
ACG Clinical Guidelines: Colorectal Cancer Screening 2021.
2
3
.
.
7. Casꢀllo Warnken V, Readi A, Rodríguez M, Lam M, López S, Cam-
paña G. Comparación entre pacientes operados por cáncer co-
lorrectal de 50 años o menores versus mayores. Rev Argent Ci-
rug. 2026; 118(1);e-1910-hꢂp//dx.doi.org/10.25132/raac.v118.
n1.1910.
Am
J Gastroenterol. 2021; 116(3): 458-79. doi: 10.14309/
ajg.0000000000001122.
Díaz-Gay M, dos Santos W, Moody S et al. Geographic and age vari-
4
5
6
.
.
.
8. Goddard KAB, Feuer EJ, Mandelblaꢂ JS, Meza R, Holford TR, Jeon
Jet al. Esꢀmaꢀon of cancer deaths averted from prevenꢀon,
screening and treatment efforts, 1975-202. JAMA Oncol 2025;
11(2): 162-167. Doi:10.1001/jamaoncol.2024.5381.
9. NCCN Guidelines in Oncology. Colorectal Cancer Screening. Ver-
sion 1.2026. hꢂps://www.nccn.org/professionals/physician_gls/
pdf/colorectal_screening.pdf
Siegel RL, Wagle NS, Jemal A. Leading Cancer Deaths in People
Younger Than 50 Years. JAMA. 2026;335;(7):632-4. doi:10.1001/
jama.2025.25467 Published online January 22, 2026.
Wang L. Idenꢀfies Potenꢀal Warning Signs of Colorectal Cancer